| Neovascular age-related macular degeneration (nAMD) presents a significant treatment burden for patients, carers and medical retina services. |
| However, significant debate remains regarding how best to manage nAMD when assessing disease activity, the significance of different types of fluid and how the understanding of anatomical efficacy can influence treatment strategies. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.